Dear Visitor, we are happy to welcome you on the redesigned website of CRS. We are glad that we can present a broad range of our expertises and services in a new style. Please feel free to have a look and to get an impression on CRS - the leading Early Phase full-service CRO in Europe.
CRS is a leading European full-service contract research organisation (CRO). It offers a complete range of high-quality clinical development and consulting services to companies operating in pharmaceuticals, biotechnology, medical devices and alimentary supplementation. The key factors in CRS's success are its rigorous client focus, its valued reliability and flexibility, and its ability to meet the very highest expectations.
CRS's excellent track record is based on over three decades of experience in clinical research combined with a dedicated and highly motivated team. CRS provides its services as a fully integrated array as well as on a modular basis.
Find out why clients from pharmaceutical, biotec and medical device companies of all sizes choose to work with CRS as their CRO of choice.
We are pleased to serve our clients with the opening of a brand new, state of the art facility, located on the campus of the University Hospital Schleswig-Holstein (UKSH).[more]
Mannheim expands its room capabilities with the opening of three new multifunctional observation rooms with 36 beds. This extension is placing CRS on the top position in Europe for large clinical trials (TQT, PK, PD).
Visit us on the Partnerships in Clinical Trials 2013 in Orlando in April. We would be glad to meet you at our booth no. 420.
To learn more about CRS have a look on a biosimilar case study. Therein, a treatment with a mAB in healthy volunteers under high logistical challenges with regard to safety, sample size and time was accomplished. [more]
